申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US04600540A1
公开(公告)日:1986-07-15
Benzoylpropionic acid derivatives represented by the general formula ##STR1## (wherein R.sup.1 represents a hydrogen atom, a lower alkyl group or a benzyl group, R.sup.2 represents a lower alkyl group or a phenyl group, X represents a hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxy group, a phenoxy group or a halogenophenoxy group, and Y represents a hydrogen atom or a lower alkyl group). The compounds have immunomodulative function and are effective for treatment of diseases caused by abnormal immunofunction.
一般式为 ##STR1## 的苯甲酸丙酯衍生物(其中 R.sup.1 代表氢原子、较低的烷基或苄基,R.sup.2 代表较低的烷基或苯基,X 代表氢原子、卤素原子、较低的烷基、较低的烷氧基、苯氧基或卤代苯氧基,Y 代表氢原子或较低的烷基)。这些化合物具有免疫调节功能,并且对于由异常免疫功能引起的疾病具有治疗作用。